| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Stuart F Quan | Q67168313 |
| P2093 | author name string | Sairam Parthasarathy | |
| Stuart F Quan | |||
| Rohit Budhiraja | |||
| P2860 | cites work | Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin | Q74206332 |
| Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease | Q74232819 | ||
| Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells | Q77363585 | ||
| Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis | Q77554947 | ||
| Sleep disordered breathing and hypertension | Q80468444 | ||
| Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome | Q83896565 | ||
| Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor | Q24317407 | ||
| Atherosclerosis | Q24644573 | ||
| Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension | Q28301973 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor | Q30829120 | ||
| Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials | Q30954736 | ||
| Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease | Q33194719 | ||
| Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells | Q33216082 | ||
| Vascular-bed--specific hemostasis and hypercoagulable states | Q33637363 | ||
| Cellular adhesion molecules and atherogenesis | Q33686005 | ||
| Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin | Q34056920 | ||
| Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients | Q34122262 | ||
| Structure and function of xanthine oxidoreductase: where are we now? | Q34147328 | ||
| Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment | Q34227249 | ||
| Endothelial dysfunction in pulmonary hypertension | Q34291213 | ||
| Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. | Q34419957 | ||
| Uric acid and oxidative stress | Q34479299 | ||
| Obstructive sleep apnoea syndrome--an oxidative stress disorder | Q35066278 | ||
| Endothelial cell heterogeneity | Q35101946 | ||
| Mechanisms of oxidative stress and vascular dysfunction | Q35125992 | ||
| Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. | Q35345503 | ||
| Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy | Q35533588 | ||
| Role of endothelial dysfunction in atherosclerosis | Q35806066 | ||
| Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation | Q36203132 | ||
| Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. | Q36276576 | ||
| Sleep-disordered breathing and cardiovascular health | Q36282917 | ||
| Leptin and cardiovascular diseases | Q36345689 | ||
| Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits | Q37417521 | ||
| Regulatory functions of the vascular endothelium | Q37816182 | ||
| Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy | Q48716348 | ||
| Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. | Q48728658 | ||
| Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea | Q48729153 | ||
| Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy | Q48748953 | ||
| Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome | Q48753031 | ||
| Effects of obstructive sleep apnea on endothelin-1 and blood pressure. | Q48768740 | ||
| Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation | Q48806749 | ||
| Platelet Function and Fibrinolytic Activity in Hypertensive and Normotensive Sleep Apnea Patients | Q48823182 | ||
| Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo | Q49137523 | ||
| Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. | Q54564514 | ||
| Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue | Q56988337 | ||
| C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease | Q57605886 | ||
| Endothelium-derived relaxing factor regulates renin release in vivo | Q68025198 | ||
| Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome | Q71147324 | ||
| Close relation of endothelial function in the human coronary and peripheral circulations | Q71827302 | ||
| Ultrastructural Aspects of Platelet Adhesion on Subendothelial Structures | Q72023583 | ||
| Cell adhesion molecules in coronary artery disease | Q72811808 | ||
| Circulating endothelin-1 in obstructive sleep apnea | Q73544211 | ||
| Leptin enhances the calcification of vascular cells: artery wall as a target of leptin | Q38300605 | ||
| Leptin induces oxidative stress in human endothelial cells. | Q38323335 | ||
| Leptin, the product of Ob gene, promotes angiogenesis | Q38331380 | ||
| Biological action of leptin as an angiogenic factor | Q38333557 | ||
| Leptin promotes vascular remodeling and neointimal growth in mice. | Q38348074 | ||
| Oxygen-derived free radicals in postischemic tissue injury | Q39492590 | ||
| Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force | Q39605814 | ||
| Vibration enhances interleukin-8 release in a cell model of snoring-induced airway inflammation. | Q40349977 | ||
| Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration | Q40429752 | ||
| Soluble P-selectin and the risk of future cardiovascular events | Q40729226 | ||
| Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries | Q41381379 | ||
| Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure | Q43634585 | ||
| Renin uptake by the endothelium mediates vascular angiotensin formation | Q43710007 | ||
| Evidence for lipid peroxidation in obstructive sleep apnea | Q43800410 | ||
| Leptin stimulates rat aortic smooth muscle cell proliferation and migration. | Q43812961 | ||
| Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute | Q43814939 | ||
| Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? | Q44172128 | ||
| Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells: a possible link to pan-coronary syndromes. | Q44285202 | ||
| Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea | Q44387214 | ||
| Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease | Q44477930 | ||
| Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism | Q44638393 | ||
| Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients | Q44649433 | ||
| Cardiac oxidative stress in acute and chronic isoproterenol-infused rats | Q45203253 | ||
| Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine | Q45238935 | ||
| Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder | Q46438800 | ||
| Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome | Q46638844 | ||
| Antioxidant vitamin C improves endothelial function in obstructive sleep apnea | Q46913805 | ||
| Recent weight gain in patients with newly diagnosed obstructive sleep apnea | Q47257483 | ||
| Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure | Q47742694 | ||
| Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension | Q47921770 | ||
| Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction | Q48478550 | ||
| Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. | Q48480506 | ||
| Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease | Q48481292 | ||
| Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea | Q48488578 | ||
| Plasma levels of vascular endothelial markers in obstructive sleep apnea | Q48504520 | ||
| Plasma adhesion molecules in children with sleep-disordered breathing | Q48505349 | ||
| Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure | Q48507311 | ||
| Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome | Q48516715 | ||
| Endothelial Function in Obstructive Sleep Apnea and Response to Treatment | Q48616765 | ||
| Sleep apnea and markers of vascular endothelial function in a large community sample of older adults | Q48616776 | ||
| Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure | Q48634373 | ||
| Elevated C-reactive protein in patients with obstructive sleep apnea | Q48660954 | ||
| Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea | Q48662343 | ||
| Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system | Q48673050 | ||
| Role of endothelin in intermittent hypoxia-induced hypertension | Q48701728 | ||
| Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. | Q48708402 | ||
| Fibrinogen levels and obstructive sleep apnea in ischemic stroke | Q48708426 | ||
| Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea | Q48709586 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 409-415 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | The Journal of Clinical Sleep Medicine | Q15766748 |
| P1476 | title | Endothelial dysfunction in obstructive sleep apnea | |
| P478 | volume | 3 |
| Q35696006 | Assessment of multiple health risks in a single obstructive sleep apnea population. |
| Q42361144 | Cardiovascular Consequences of Repetitive Arousals over the Entire Sleep Duration. |
| Q36537445 | Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
| Q36482623 | Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more |
| Q41762962 | Distressing nocturia |
| Q91726244 | Domiciliary use of transcutaneous electrical stimulation for patients with obstructive sleep apnoea: a conceptual framework for the TESLA home programme |
| Q37863567 | Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea |
| Q48436905 | Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease? |
| Q26768865 | Hypoxia: The Force that Drives Chronic Kidney Disease |
| Q47681527 | Independent Contributions of Obstructive Sleep Apnea and the Metabolic Syndrome to the Risk of Chronic Kidney Disease |
| Q46661071 | Links between lower urinary tract symptoms, intermittent hypoxia and diabetes: Causes or cures? |
| Q36741801 | Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. |
| Q57050031 | MiRNA expression profiles in healthy OSAHS and OSAHS with arterial hypertension: potential diagnostic and early warning markers |
| Q49856282 | Neural respiratory drive and cardiac function in patients with obesity hypoventilation syndrome following initiation of non-invasive ventilation. |
| Q36228769 | Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms |
| Q38676267 | Obstructive Sleep Apnea and Smoking as a Risk Factor for Venous Thromboembolism Events: Review of the Literature on the Common Pathophysiological Mechanisms. |
| Q34088531 | Obstructive sleep apnea and cardiovascular disease in blacks: a call to action from the Association of Black Cardiologists |
| Q36897409 | Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components |
| Q35070672 | Obstructive sleep apnea and progression of coronary artery calcium: the multi-ethnic study of atherosclerosis study |
| Q90324170 | Obstructive sleep apnea negatively impacts objectively measured physical activity |
| Q36396309 | Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches |
| Q37185348 | Outcomes from the Tucson Children's Assessment of Sleep Apnea Study (TuCASA). |
| Q92876865 | Relationship between the endothelial dysfunction and the expression of the β1-subunit of BK channels in a non-hypertensive sleep apnea group |
| Q38208753 | Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease |
| Q35138178 | Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management |
| Q34273305 | Sleep-disordered breathing and cardiovascular disorders |
| Q36701404 | Sleep-disordered breathing and pregnancy: potential mechanisms and evidence for maternal and fetal morbidity |
| Q34246426 | Sleep-disordered breathing is a risk factor for delirium after cardiac surgery: a prospective cohort study |
| Q34021885 | Snoring and the Risk of Obstructive Sleep Apnea in Patients with Pulmonary Embolism |
| Q90186881 | The Association Between Obstructive Sleep Apnea Characterized by a Minimum 3 Percent Oxygen Desaturation or Arousal Hypopnea Definition and Hypertension |
| Q34288892 | The Impact of Obstructive Sleep Apnea on Chronic Kidney Disease |
| Q31103452 | The Role of Big Data in the Management of Sleep-Disordered Breathing |
| Q90588763 | The cardiovascular risk in paediatrics: the paradigm of the obstructive sleep apnoea syndrome |
| Q48398185 | The coagulation and protein C pathways in patients with sleep apnea |
| Q46364653 | The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial |
| Q40792829 | The prevalence of sleep-disordered breathing among survivors of acute pulmonary embolism |
| Q35043452 | Therapeutic potential of intermittent hypoxia: a matter of dose |
| Q48025205 | Vestibular evoked myogenic potential responses in obstructive sleep apnea syndrome |
| Q43144469 | When is CPAP an antihypertensive in sleep apnea patients? |
| Q35546098 | Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats |
Search more.